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Patients with HTLV-Associated-Myelopathy (pwHAM)
predominantly have proximal leg weakness, and reduced
activities of daily living (ADLs). 92% of pwHAM attend-
ing NCHR use a walking aid and experience difficulty
with walking long distances, thus many are housebound,
or community ambulators. The 6 minute walk test
(6MWT) measures walking endurance and was mea-
sured at 2 timepoints (T1 & T2), 1 year(yr) apart. We
retrospectively analysed 36 patients’ notes (26♀: 10♂;
mean age 56.8yrs; mean duration of HAM 10.7yrs). We
correlated, regressed and t-tested 10m timed walk
(10mTW), walking aid used, pain scores, distance cov-
ered, time taken and velocity. Significant differences
were found between T1&T2 for: 6MWTime p=0.02;
6MWVelocity p=0.04 & 10mTW p=0.04. 6MW is reli-
able (ICC: 0.83).10mTW inversely correlated with the
6MWTDistance covered T1p=0.002 & T2 p=0.022 &
6MWTVelocity T1p=0.000 & T2 p=0.002.10mTW at T1
predicted 6MWDistance (p=0.004), T1 6MWVelocity
predicted T2 distance walked. Walking aids predicted
10mTW time (p=0.00 at T1 & T2); 6 MWDistance cov-
ered (T1=p=0.002;T2:p=0.00) and velocity (T1&T2:
p=0.00). Duration of disease (p=0.34), interval between
tests (p=0.57) & age (p=0.75) did not predict the 6 MWT
(distance or time) or the 10mTW. Average pain score
changed 8.3% between T1&T2 (p=0.75). No element of
the 6 MW test or the 10mTW correlated with pain at
either time point. Walking endurance is an important
component of walking capacity. The 6MWT appears to
be a reliable measure to use in patients with HAM. The
results demonstrate that pwHAM are more dependent in
their ADLs, are a falls risk, walk limited distances & have
limited endurance.
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